LAVAL, Quebec – (BUSINESS WIRE) – Altasciences is verheugd met de aanstelling van Martin Poirier, M.Sc., en kondigt hem aan als Senior Director van Bioanalytical Sciences, gevestigd in de preklinische faciliteit van Altasciences in Seattle, WA. Martin zal zijn uitgebreide kennis en ervaring inzetten om interne en externe klanten te begeleiden bij hun projecten voor bioanalyse en immunomodulatieanalyse.

De uitstekende reputatie en specialisatie van Martin op het gebied van immunologie, evenals meer dan tien jaar ervaring in het beheren van laboratoriumwetenschappen en het opzetten van nieuwe faciliteiten in Noord-Amerika, sluiten aan bij de doelstelling van Altasciences om hun preklinische en klinische bioanalytische full-service continu te verbeteren. Hij treedt toe tot het Senior Management-team en neemt verantwoordelijkheden op zich voor de groei en ontwikkeling van de preklinische bioanalytische activiteiten van Altasciences.

Altasciences Welcomes Martin Poirier as Senior Director, Bioanalytical Sciences

LAVAL, Quebec–(BUSINESS WIRE)– Altasciences is pleased to announce the appointment of Martin Poirier, M.Sc., as Senior Director of Bioanalytical Sciences, based in Altasciences’ preclinical facility in Seattle, WA. Martin will apply his extensive knowledge and experience to guide internal and external clients throughout their bioanalysis and immunomodulation analysis projects.

Martin’s outstanding industry reputation and specialization in the field of immunology, as well as more than ten years of experience managing laboratory sciences and establishing new facilities across North America, align with Altasciences’ objective of continually enhancing their full service preclinical and clinical bioanalytical capabilities. He joins the Senior Management team, and takes on responsibilities for the growth and development of Altasciences’ preclinical bioanalytical business.

“We are very pleased to welcome Martin to our growing team of experts. His years of experience and breadth of knowledge will be an asset as we develop and enhance our facilities and offerings to fully and effectively support our clients’ ever-evolving needs,” said Mike Broadhurst, General Manager of Altasciences’ Seattle site.

About Altasciences

Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, and data management, all of which can be tailored to specific sponsor requirements. Altasciences… helping sponsors get better drugs to the people who need them, faster.

View source version on businesswire.com: https://www.businesswire.com/news/home/20191112005641/en/

Contacts

Julie-Ann Cabana
Altasciences
913 304-4505
jcabana@altasciences.com